Korsana Biosciences, Inc. (KRSA)
NASDAQ: KRSA · Real-Time Price · USD
33.79
-0.53 (-1.54%)
At close: Oct 15, 2026, 4:00 PM EDT
33.65
-0.14 (-0.41%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Korsana Biosciences Earnings Call Transcripts
Fiscal Year 2026
-
The all-stock merger pairs a ~$380 million private placement with KRSA-028 development, with cash runway expected into 2029. The program targets key clinical readouts in 2027, subject to merger approval and completion.